GB9326425D0 - Vaccine compositions - Google Patents

Vaccine compositions

Info

Publication number
GB9326425D0
GB9326425D0 GB939326425A GB9326425A GB9326425D0 GB 9326425 D0 GB9326425 D0 GB 9326425D0 GB 939326425 A GB939326425 A GB 939326425A GB 9326425 A GB9326425 A GB 9326425A GB 9326425 D0 GB9326425 D0 GB 9326425D0
Authority
GB
United Kingdom
Prior art keywords
vaccine compositions
vaccine
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939326425A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Defence
Original Assignee
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Defence filed Critical UK Secretary of State for Defence
Priority to GB939326425A priority Critical patent/GB9326425D0/en
Publication of GB9326425D0 publication Critical patent/GB9326425D0/en
Priority to CA002179639A priority patent/CA2179639A1/en
Priority to AU13222/95A priority patent/AU1322295A/en
Priority to EP95904620A priority patent/EP0741786A1/de
Priority to JP7517658A priority patent/JPH09507028A/ja
Priority to PCT/GB1994/002818 priority patent/WO1995018231A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB939326425A 1993-12-24 1993-12-24 Vaccine compositions Pending GB9326425D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB939326425A GB9326425D0 (en) 1993-12-24 1993-12-24 Vaccine compositions
CA002179639A CA2179639A1 (en) 1993-12-24 1994-12-23 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection
AU13222/95A AU1322295A (en) 1993-12-24 1994-12-23 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection
EP95904620A EP0741786A1 (de) 1993-12-24 1994-12-23 Auf bakteriellen Vektoren basierende Vakzine, die Schutz gegen Infektionen durch Yersinia pestis gewährt
JP7517658A JPH09507028A (ja) 1993-12-24 1994-12-23 イエルシニア ペスチス （Ｙｅｒｓｉｎｉａ ｐｅｓｔｉｓ）感染から防御するための生細菌ベクターを含むワクチン組成物
PCT/GB1994/002818 WO1995018231A1 (en) 1993-12-24 1994-12-23 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939326425A GB9326425D0 (en) 1993-12-24 1993-12-24 Vaccine compositions

Publications (1)

Publication Number Publication Date
GB9326425D0 true GB9326425D0 (en) 1994-02-23

Family

ID=10747201

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939326425A Pending GB9326425D0 (en) 1993-12-24 1993-12-24 Vaccine compositions

Country Status (6)

Country Link
EP (1) EP0741786A1 (de)
JP (1) JPH09507028A (de)
AU (1) AU1322295A (de)
CA (1) CA2179639A1 (de)
GB (1) GB9326425D0 (de)
WO (1) WO1995018231A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070043215A1 (en) * 1996-08-27 2007-02-22 Heath David G Recombinant f1-v plague vaccine
WO1998024912A2 (en) * 1996-12-04 1998-06-11 Heska Corporation Recombinant plague vaccine
EP1176966B1 (de) * 1999-04-12 2013-04-03 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Oligodeoxynukleotide und deren verwendung zur induktion einer immunreaktion
GB9921275D0 (en) * 1999-09-10 1999-11-10 Secr Defence Recombinant microorganisms
ATE378348T1 (de) 2000-01-14 2007-11-15 Us Health Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
GB0220257D0 (en) 2002-08-31 2002-10-09 Secr Defence Vaccine
US7344718B2 (en) 2003-01-31 2008-03-18 University Of North Dakota Yersinia species compositions
WO2012178078A2 (en) 2011-06-22 2012-12-27 University Of North Dakota Use of yscf, truncated yscf and yscf homologs as adjuvants
IN2014DN09618A (de) 2012-05-23 2015-07-31 Us Sec Dep Of Health And Human Services

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0474891A1 (de) * 1990-09-08 1992-03-18 BEHRINGWERKE Aktiengesellschaft Vektoren für die Expression malarialer Antigene an der Oberfläche von Salmonella Vakzinstämmen
JP3601602B2 (ja) * 1990-11-09 2004-12-15 ワシントン ユニバーシティ 無毒性微生物及びその使用：サルモネラ

Also Published As

Publication number Publication date
CA2179639A1 (en) 1995-07-06
WO1995018231A1 (en) 1995-07-06
EP0741786A1 (de) 1996-11-13
JPH09507028A (ja) 1997-07-15
AU1322295A (en) 1995-07-17

Similar Documents

Publication Publication Date Title
AP9400629A0 (en) Vaccine compositions
AP9300502A0 (en) Vaccine compositions
IL118004A0 (en) Vaccine compositions
PL315128A1 (en) Anti-pollutant compositions
IL110665A0 (en) Erection-inducing compositions
GB9503863D0 (en) Vaccine compositions
IL108681A0 (en) Influenza vaccine compositions
GB9318641D0 (en) Compositions
PL313979A1 (en) Vaccine composition
GB9323313D0 (en) Clenasing compositions
GB9404236D0 (en) Cable-making compositions
GB9326425D0 (en) Vaccine compositions
SG48119A1 (en) Compositions
GB9313759D0 (en) Cementiferous compositions
GB9320454D0 (en) Vaccine compositions
GB9306029D0 (en) Vaccine compositions
GB9403417D0 (en) Vaccine compositions
GB9601739D0 (en) Vaccine Compositions
GB9425980D0 (en) Vaccine compositions
GB9416097D0 (en) Vaccine compositions
GB9324743D0 (en) Adjuvant compositions
GB9314206D0 (en) Compositions
GB9306937D0 (en) Anaestetic compositions
GB9306033D0 (en) Compositions
GB9304400D0 (en) Pharmaceuticla compositions